MEIS1 in Hematopoiesis and Cancer. How MEIS1-PBX Interaction Can Be Used in Therapy

Overview

Journal J Dev Biol

Specialty Biology

Date 2021 Oct 26

PMID 34698191

Citations 3

Authors

Francesco Blasi

Chiara Bruckmann

Affiliations

Soon will be listed here.

Abstract

Recently MEIS1 emerged as a major determinant of the MLL-r leukemic phenotype. The latest and most efficient drugs effectively decrease the levels of MEIS1 in cancer cells. Together with an overview of the latest drugs developed to target MEIS1 in MLL-r leukemia, we review, in detail, the role of MEIS1 in embryonic and adult hematopoiesis and suggest how a more profound knowledge of MEIS1 biochemistry can be used to design potent and effective drugs against MLL-r leukemia. In addition, we present data showing that the interaction between MEIS1 and PBX1 can be blocked efficiently and might represent a new avenue in anti-MLL-r and anti-leukemic therapy.

Citing Articles

The HOX code of human adult fibroblasts reflects their ectomesenchymal or mesodermal origin.

Pfeiferova L, Spanko M, Sachova J, Hradilova M, Pienta K, Valach J Histochem Cell Biol. 2025; 163(1):38.

PMID: 40063181 PMC: 11893657. DOI: 10.1007/s00418-025-02362-9.

The impact of TALE homeodomain transcription factor knockdown on glioma stem cell growth.

Kim H, Batara D, Jeon Y, Lee S, Beck S, Kim S Anim Cells Syst (Seoul). 2024; 28(1):93-109.

PMID: 38487309 PMC: 10939110. DOI: 10.1080/19768354.2024.2327340.

The MLL-Menin Interaction is a Therapeutic Vulnerability in -rearranged AML.

Rasouli M, Blair H, Troester S, Szoltysek K, Cameron R, Ashtiani M Hemasphere. 2023; 7(8):e935.

PMID: 37520776 PMC: 10378738. DOI: 10.1097/HS9.0000000000000935.

Special Issue "Hox Genes in Development: New Paradigms".

Merabet S J Dev Biol. 2022; 10(3).

PMID: 35997398 PMC: 9397022. DOI: 10.3390/jdb10030034.

References

Cathiard L, Fraulob V, Lam D, Torres M, Winkelmann J, Krezel W . Investigation of dopaminergic signalling in Meis homeobox 1 (Meis1) deficient mice as an animal model of restless legs syndrome. J Sleep Res. 2021; 30(5):e13311. DOI: 10.1111/jsr.13311. View

Spieker N, van Sluis P, Beitsma M, Boon K, van Schaik B, van Kampen A . The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32. Genomics. 2001; 71(2):214-21. DOI: 10.1006/geno.2000.6408. View

Lopez-Delgado A, Delgado I, Cadenas V, Sanchez-Cabo F, Torres M . Axial skeleton anterior-posterior patterning is regulated through feedback regulation between Meis transcription factors and retinoic acid. Development. 2020; 148(1). DOI: 10.1242/dev.193813. View

Girgin B, KaradaG-Alpaslan M, Kocabas F . Oncogenic and tumor suppressor function of MEIS and associated factors. Turk J Biol. 2021; 44(6):328-355. PMC: 7759197. DOI: 10.3906/biy-2006-25. View

Lawrence H, Helgason C, Sauvageau G, Fong S, Izon D, Humphries R . Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood. 1997; 89(6):1922-30. View

Schnabel C, Jacobs Y, Cleary M . HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis. Oncogene. 2000; 19(5):608-16. DOI: 10.1038/sj.onc.1203371. View

Brunetti L, Gundry M, Sorcini D, Guzman A, Huang Y, Ramabadran R . Mutant NPM1 Maintains the Leukemic State through HOX Expression. Cancer Cell. 2018; 34(3):499-512.e9. PMC: 6159911. DOI: 10.1016/j.ccell.2018.08.005. View

Krivtsov A, Armstrong S . MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer. 2007; 7(11):823-33. DOI: 10.1038/nrc2253. View

Dardaei L, Longobardi E, Blasi F . Prep1 and Meis1 competition for Pbx1 binding regulates protein stability and tumorigenesis. Proc Natl Acad Sci U S A. 2014; 111(10):E896-905. PMC: 3956142. DOI: 10.1073/pnas.1321200111. View

10.

Gibbons G, Chakraborty A, Grigsby S, Umeano A, Liao C, Moukha-Chafiq O . Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library. Eur J Med Chem. 2020; 189:112023. PMC: 7646624. DOI: 10.1016/j.ejmech.2019.112023. View

11.

Mamo A, Krosl J, Kroon E, Bijl J, Thompson A, Mayotte N . Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation. Blood. 2006; 108(2):622-9. DOI: 10.1182/blood-2005-06-2244. View

12.

Gundry M, Goodell M, Brunetti L . It's All About MEis: Menin-MLL Inhibition Eradicates NPM1-Mutated and MLL-Rearranged Acute Leukemias in Mice. Cancer Cell. 2020; 37(3):267-269. DOI: 10.1016/j.ccell.2020.02.011. View

13.

Wang G, Pasillas M, Kamps M . Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus. Blood. 2005; 106(1):254-64. PMC: 1895124. DOI: 10.1182/blood-2004-12-4664. View

14.

Ayton P, Cleary M . Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene. 2001; 20(40):5695-707. DOI: 10.1038/sj.onc.1204639. View

15.

Yao M, Gu Y, Yang Z, Zhong K, Chen Z . MEIS1 and its potential as a cancer therapeutic target (Review). Int J Mol Med. 2021; 48(3). PMC: 8354308. DOI: 10.3892/ijmm.2021.5014. View

16.

Lane J, Liang J, Vlasac I, Anderson S, Bechtold D, Bowden J . Genome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traits. Nat Genet. 2016; 49(2):274-281. PMC: 5491693. DOI: 10.1038/ng.3749. View

17.

Dardaei L, Modica L, Iotti G, Blasi F . The deficiency of tumor suppressor prep1 accelerates the onset of meis1- hoxa9 leukemogenesis. PLoS One. 2014; 9(5):e96711. PMC: 4014505. DOI: 10.1371/journal.pone.0096711. View

18.

Ferretti E, Villaescusa J, Di Rosa P, Fernandez-Diaz L, Longobardi E, Mazzieri R . Hypomorphic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype. Mol Cell Biol. 2006; 26(15):5650-62. PMC: 1592771. DOI: 10.1128/MCB.00313-06. View

19.

Thorsteinsdottir U, Kroon E, Jerome L, Blasi F, Sauvageau G . Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia. Mol Cell Biol. 2000; 21(1):224-34. PMC: 88796. DOI: 10.1128/MCB.21.1.224-234.2001. View

20.

Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg A, Sauvageau G . Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 1998; 17(13):3714-25. PMC: 1170707. DOI: 10.1093/emboj/17.13.3714. View